Sirona Biochem Corp (SBM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sirona Biochem Corp (SBM) has a cash flow conversion efficiency ratio of 0.160x as of July 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-552.59K ≈ $-399.74K USD) by net assets (CA$-3.46 Million ≈ $-2.51 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Sirona Biochem Corp to measure how much of total assets are equity-financed.
Sirona Biochem Corp - Cash Flow Conversion Efficiency Trend (2011–2023)
This chart illustrates how Sirona Biochem Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Sirona Biochem Corp cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Sirona Biochem Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sirona Biochem Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CLEANTEK Industries Inc
V:CTEK
|
0.193x |
|
American Manganese Inc
V:AMY
|
-0.045x |
|
High Coast Distillery AB
ST:HIGHCO-B
|
0.005x |
|
Dycasa SA
BA:DYCA
|
-0.135x |
|
InnSuites Hospitality Trust
NYSE MKT:IHT
|
0.988x |
|
Asturiana de Laminados S.A.
MC:ELZ
|
0.921x |
|
AUGA GROUP AB EO 029
F:W9Z
|
0.032x |
|
RedCloud Holdings plc Ordinary Shares
NASDAQ:RCT
|
3.026x |
Annual Cash Flow Conversion Efficiency for Sirona Biochem Corp (2011–2023)
The table below shows the annual cash flow conversion efficiency of Sirona Biochem Corp from 2011 to 2023. For the full company profile with market capitalisation and key ratios, see SBM market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-10-31 | CA$-2.51 Million ≈ $-1.82 Million |
CA$-1.76 Million ≈ $-1.27 Million |
0.700x | +106.89% |
| 2022-10-31 | CA$214.51K ≈ $155.18K |
CA$-2.18 Million ≈ $-1.58 Million |
-10.151x | -145.63% |
| 2021-10-31 | CA$-97.02K ≈ $-70.18K |
CA$-2.16 Million ≈ $-1.56 Million |
22.246x | +149.92% |
| 2020-10-31 | CA$47.40K ≈ $34.28K |
CA$-2.11 Million ≈ $-1.53 Million |
-44.564x | -2641.24% |
| 2019-10-31 | CA$2.19 Million ≈ $1.58 Million |
CA$-3.56 Million ≈ $-2.57 Million |
-1.626x | -719.47% |
| 2018-10-31 | CA$-2.26 Million ≈ $-1.64 Million |
CA$-593.35K ≈ $-429.22K |
0.262x | -78.57% |
| 2017-10-31 | CA$-2.04 Million ≈ $-1.48 Million |
CA$-2.50 Million ≈ $-1.81 Million |
1.225x | +191.01% |
| 2016-10-31 | CA$1.56 Million ≈ $1.13 Million |
CA$-2.10 Million ≈ $-1.52 Million |
-1.346x | +5.71% |
| 2015-10-31 | CA$2.15 Million ≈ $1.55 Million |
CA$-3.06 Million ≈ $-2.22 Million |
-1.427x | -37.36% |
| 2014-10-31 | CA$1.79 Million ≈ $1.30 Million |
CA$-1.86 Million ≈ $-1.35 Million |
-1.039x | +10.78% |
| 2013-10-31 | CA$2.15 Million ≈ $1.55 Million |
CA$-2.50 Million ≈ $-1.81 Million |
-1.164x | +7.70% |
| 2012-10-31 | CA$1.70 Million ≈ $1.23 Million |
CA$-2.15 Million ≈ $-1.55 Million |
-1.261x | -35.27% |
| 2011-10-31 | CA$2.72 Million ≈ $1.97 Million |
CA$-2.54 Million ≈ $-1.84 Million |
-0.933x | -- |
About Sirona Biochem Corp
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company … Read more